Urovant Sciences Ltd. announced replacement of Mr. Frank M. Torti, M.D., as a director with Dr. Shigeyuki Nishinaka. Dr. Nishinaka will serve on the Nominating, Corporate Governance and Compliance Oversight Committee of the Board. On December 22, 2019, Mr. Torti, M.D. delivered a notice to the company in accordance with bye-law 41.1(d) of the Bye-laws, resigning as a director effective as of December 27, 2019.